Fact-checked by Grok 2 weeks ago

Echogenicity

Echogenicity refers to the ability of a or structure to reflect waves back to the , determining its relative brightness on an image compared to surrounding s. This property arises from differences in at interfaces, where impedance is a measure of a material's to the of waves, calculated as the product of density and the within it. In ultrasound imaging, echogenicity is categorized into distinct levels to aid interpretation: anechoic structures produce no echoes and appear black (e.g., fluid-filled cysts or blood vessels); hypoechoic structures reflect few waves and appear as darker shades of gray (e.g., muscle or certain tumors); isoechoic structures have similar reflectivity to adjacent s, making them harder to distinguish; and hyperechoic structures reflect strongly and appear bright white (e.g., , calcifications, or fibrotic ). These variations enable clear visualization of anatomical boundaries and pathological changes, with image contrast enhanced by the angle of incidence and beam characteristics. Clinically, echogenicity assessment is fundamental across ultrasound modalities, including abdominal, obstetric, vascular, and musculoskeletal imaging, where it helps identify abnormalities such as steatosis (increased liver echogenicity), cysts, or inflammation. Factors like tissue composition, pathology, and even patient positioning can alter echogenicity, influencing diagnostic accuracy and guiding interventions like biopsies or needle placements. Advances in ultrasound technology, such as harmonic imaging, further refine echogenicity evaluation by reducing artifacts and improving resolution.

Fundamentals

Definition

Echogenicity refers to the ability of a structure or to reflect waves back to the , producing echoes that manifest as varying degrees of brightness on images. This reflection occurs at interfaces between tissues with differing acoustic properties, determining the appearance where stronger echoes yield brighter (more echogenic) regions. The assessment of echogenicity is inherently relative, typically evaluated in comparison to adjacent tissues or established reference standards, such as the of the right , which is used as a reference for assessing liver echogenicity in abdominal . This comparative approach allows clinicians to identify deviations that may indicate underlying structural differences. The term echogenicity arose during the development of diagnostic in the mid-20th century, amid advancements in technologies pioneered in the and . It gained widespread adoption in the , particularly with the expansion of abdominal imaging techniques that relied on patterns for characterization. Early literature from this period, such as studies on fatty s, highlighted echogenicity as a key descriptor for distinguishing normal and abnormal structures. In the fundamental imaging process, an ultrasound transducer emits high-frequency sound waves that travel through the body until they encounter boundaries; the returning echoes are detected, amplified, and processed into a two-dimensional , with intensity levels directly corresponding to the degree of echogenicity. This conversion relies on the principle that greater reflection due to differences in results in higher signal amplitude and thus brighter display.

Descriptive Terms

In ultrasound imaging, echogenicity is qualitatively described using standardized terms that reflect the relative intensity of echoes returned from tissues, aiding in the visual interpretation of images. These terms categorize structures based on their appearance on the grayscale display, where brighter areas indicate stronger echo reflection and darker areas indicate weaker or absent reflection. Hyperechoic structures appear brighter than surrounding tissues due to strong echo returns, often seen in dense materials such as bone or calcifications. Hypoechoic structures, in contrast, appear darker than adjacent tissues, as exemplified by muscle when imaged relative to fat. Anechoic regions produce no detectable echoes, resulting in a completely black appearance on the image, typically observed in fluid-filled cysts or blood vessels. Isoechoic structures exhibit echogenicity similar to neighboring tissues, which can complicate differentiation without additional contextual features like shape or location. The grayscale scale in images ranges from black, representing no reflection (anechoic), through various mid-tones for intermediate echogenicity levels, to white for strong reflection (hyperechoic), allowing for nuanced visual assessment of interfaces. These descriptive terms are essential in radiological reporting, as they promote consistent and precise communication among radiologists and clinicians, facilitating accurate diagnosis and treatment planning.

Physical Principles

Acoustic Impedance

Acoustic impedance, denoted as Z, represents the opposition a medium offers to the propagation of waves and is a key determinant of echo production at tissue interfaces. It is defined as the product of the medium's \rho (in kg/m³) and the c (in m/s) within that medium, expressed by the formula
Z = \rho \times c.
This property arises from the in acoustics, where and must satisfy boundary conditions at interfaces, leading to the impedance as the ratio of acoustic to particle velocity.
The unit of acoustic impedance is the rayl (kg/m²·s), commonly reported in mega-rayls (10⁶ rayls) for practical use in . Representative values illustrate the range across media: air has an acoustic impedance of 0.0004 × 10⁶ rayls, 1.48 × 10⁶ rayls, 1.5–1.7 × 10⁶ rayls, and 7.8 × 10⁶ rayls. These differences highlight why transmission is poor in air but feasible in aqueous biological environments. The c, a component of the formula, varies by type to differences in elasticity and , influencing overall echogenicity. In , c is approximately 1540 m/s; it is lower in at 1450 m/s and significantly higher in at 4080 m/s. These variations contribute to impedance mismatches, as even similar densities can yield differing Z values when combined with disparate speeds. In the context of echogenicity, a mismatch in \Delta Z between two adjacent media causes partial of the incident wave at their , with the reflected portion forming the detectable . Greater impedance differences produce stronger reflections, enabling of boundaries in ; for instance, the large mismatch between and results in prominent echoes. This is quantified by the amplitude reflection coefficient R, derived from the continuity of and normal component of at the under incidence. Assuming plane waves, the incident p_i, reflected p_r, and transmitted p_t satisfy p_i + p_r = p_t and (p_i - p_r)/Z_1 = p_t / Z_2, solving which yields
R = \frac{p_r}{p_i} = \frac{Z_2 - Z_1}{Z_2 + Z_1},
where Z_1 and Z_2 are the impedances of the incident and transmitting media, respectively. The fraction of incident intensity reflected, which directly relates to echo strength, is then |R|^2.

Wave Reflection and Scattering

In ultrasound imaging, echoes are generated when encounter interfaces, primarily through the processes of and , which determine the echogenicity observed in images. Reflection occurs due to mismatch at boundaries, directing waves back toward the to form bright echoes. These mechanisms are fundamental to , as the intensity and pattern of returning echoes create the representation of structures. Specular reflection, also known as mirror-like reflection, happens at smooth interfaces larger than the and oriented perpendicular to the beam, such as vessel walls or organ capsules, resulting in a strong, directional that appears hyperechoic on the . This type of reflection efficiently returns energy to the only when the incidence angle is near normal, producing distinct linear or curvilinear bright lines in the ultrasound display. For example, the walls of major blood vessels often exhibit due to their smooth, planar surfaces. In contrast, scattering involves diffuse redirection of waves from rough or irregular surfaces and small scatterers comparable to or smaller than the , leading to propagation and the characteristic speckled in parenchymal tissues. When scatterers are much smaller than the (typically less than λ/10, where λ is the ), predominates, as seen in blood where red blood cells act as weak scatterers, contributing to low echogenicity in fluid-filled structures. This diffuse ensures some energy returns to the from various angles, enhancing the visibility of heterogeneous tissues like liver . The backscattering coefficient quantifies the fraction of incident energy scattered back toward the from a given volume of , directly influencing the or echogenicity in the resulting image. Higher backscattering coefficients, often from dense or heterogeneous microstructures, produce stronger echoes and brighter regions, while lower values result in darker appearances; this parameter is frequency-dependent and used to characterize properties quantitatively. Attenuation progressively reduces echo intensity with depth due to (conversion to heat) and , limiting the detection of deeper structures and contributing to the overall dimming of echogenicity in far-field images. accounts for a portion of this loss by redirecting waves away from the path, while dominates in soft tissues, with the combined effect causing in signal strength. Ultrasound beam properties, particularly , modulate these and behaviors: higher frequencies (e.g., 7–15 MHz) enhance axial by shortening , increasing from small structures but also amplifying , which reduces and weakens deeper echoes. Lower frequencies (e.g., 2–5 MHz) allow greater penetration for abdominal imaging but yield coarser and less pronounced effects. This trade-off is critical for selecting settings to optimize echogenicity in specific clinical contexts.

Factors Affecting Echogenicity

Tissue Composition

Body fluids, including , , and , display low echogenicity and typically appear anechoic on ultrasound images. This characteristic arises from their homogeneous composition, which provides minimal interfaces for ultrasound wave or , allowing most sound waves to pass through without generating detectable echoes. In solid tissues, echogenicity varies significantly based on the ratio of to content. Fatty tissues generally appear hyperechoic relative to surrounding structures such as muscle due to multiple interfaces created by lobules and fibrous septa, while fibrous tissues with higher concentrations are hyperechoic, as fibers create multiple interfaces that enhance reflection. Liver serves as a common reference for moderate echogenicity in abdominal , exhibiting a uniform texture that balances these components in healthy individuals. Strong echoes often originate at interfaces between different types, such as the boundary between muscle and , where substantial differences in lead to pronounced reflection of waves. At the level, intracellular structures like nuclei and organelles function as primary of waves, contributing to overall echogenicity. Higher density amplifies this effect by increasing the number of scattering sites, resulting in greater echo return and brighter appearance on images. Organ-specific variations highlight these principles in normal anatomy. The thyroid gland typically presents as homogeneous and isoechoic to adjacent muscle, reflecting its balanced fibro-glandular composition. In the , the appears hyperechoic relative to the medulla, owing to its denser cellular and stromal elements compared to the more fluid-like medullary pyramids.

Pathological Changes

Pathological changes in tissues often alter echogenicity by modifying acoustic interfaces, leading to distinct appearances that serve as diagnostic clues. Cysts and typically result in anechoic or hypoechoic patterns due to fluid accumulation, which minimizes internal echoes. For instance, simple ovarian cysts appear as well-defined, anechoic structures with thin walls and no internal septations or solid components, reflecting their fluid-filled nature without significant or . Similarly, subcutaneous manifests as hypoechoic or mixed echogenicity in the soft tissues, with thickened subcutaneous layers showing linear hypoechoic areas amid increased overall echogenicity due to fluid distribution. Fibrosis and calcification increase tissue echogenicity by creating dense acoustic barriers that enhance reflection and scattering. In liver cirrhosis, advanced fibrosis leads to diffusely increased parenchymal echogenicity, often with coarsened texture and reduced beam penetration, distinguishing it from normal liver appearance. Calcifications, such as those in chronic liver disease or vascular structures, appear markedly hyperechoic with prominent posterior acoustic shadowing, as the high acoustic impedance mismatch blocks sound wave transmission. Tumors exhibit variable echogenicity depending on their cellularity, vascularity, and composition, providing key discriminatory features. Malignant tumors like carcinoma are frequently hypoechoic with irregular borders and may show an echogenic halo at the periphery, indicating invasive growth into surrounding tissues. In contrast, benign tumors such as fibroadenomas often display hypoechoic patterns relative to adjacent tissue, with well-circumscribed margins and uniform internal echoes due to their fibromyxoid stroma. Inflammation alters echogenicity through hyperemia, , and cellular infiltration, typically increasing reflectivity in affected areas. Acute , for example, is associated with increased echogenicity in the periappendiceal mesenteric fat, appearing as a hyperechoic rim around the inflamed due to inflammatory changes in the . Fatty infiltration, as seen in hepatic , results in hyperechoic liver because lipid droplets scatter waves more intensely than normal hepatocytes. This "bright liver" appearance on correlates with the degree of , often obscuring deeper structures and mimicking other hyperechoic pathologies.

Clinical Applications

Diagnostic Interpretation

In diagnostic , echogenicity patterns are evaluated through recognition of homogeneous versus heterogeneous echotexture to guide . Homogeneous echotexture, appearing uniform in echo intensity, often suggests benign conditions, while heterogeneous echotexture, characterized by mixed areas of varying echo levels, raises suspicion for , as seen in breast lesions where heterogeneity correlates with increased malignant potential. In nodules, heterogeneous echogenicity of the can complicate differentiation but is associated with higher risk when present in the nodule itself. Posterior acoustic effects further refine interpretation by indicating tissue attenuation properties. Acoustic enhancement, an increase in echogenicity behind low-attenuation structures, is a hallmark of fluid-filled cysts, aiding their identification from solid masses. Conversely, acoustic shadowing, a hypoechoic or anechoic region posterior to high-attenuation structures like gallstones, confirms dense calculi and distinguishes them from softer lesions. These effects provide critical context for benign versus pathological diagnoses without invasive procedures. Integration of Doppler ultrasound with echogenicity enhances vascular assessment for comprehensive lesion characterization. Color and power Doppler reveal blood flow patterns, such as hypervascularity with irregular vessels in malignant soft-tissue masses, complementing hypoechoic or heterogeneous echotexture to improve specificity over grayscale alone. Organ-specific protocols leverage these features; for instance, a hyperechoic liver parenchyma on ultrasound indicates fatty infiltration in steatotic liver disease, prompting further metabolic evaluation. In thyroid imaging, the ACR TI-RADS system assigns risk points based on echogenicity—0 for anechoic, 1 for hyperechoic or isoechoic, 2 for hypoechoic, and 3 for very hypoechoic—stratifying nodules for biopsy when combined with other traits, with malignancy risk escalating from <2% in low-point categories to >20% in high-point ones. Despite these strengths, echogenicity interpretation faces limitations due to dependence and equipment variability. Subjective assessments of echo patterns can vary between sonographers, reducing compared to or MRI. settings, which amplify signal intensity, alter perceived echogenicity, potentially over- or underestimating tissue characteristics if not standardized, underscoring the need for protocol uniformity and training to mitigate these issues.

Contrast Enhancement Techniques

Contrast enhancement techniques in ultrasound aim to improve the visualization of structures with inherently low echogenicity by leveraging instrumental adjustments and non-invasive methods, thereby enhancing diagnostic accuracy without relying on exogenous contrast agents. These approaches modify or acquisition to amplify, filter, or average echoes, reducing artifacts and improving contrast resolution. exploits the nonlinear propagation of ultrasound waves through tissues, generating higher-frequency harmonics that provide enhanced contrast. In this technique, the transducer transmits at a , typically in the range of 1-5 MHz, but receives and processes signals at the second harmonic frequency (twice the fundamental), which arises from tissue distortion during wave propagation. This results in improved definition and reduced near-field clutter, as the harmonic signals are less affected by aberrations from superficial structures. Studies have demonstrated that significantly enhances the depiction of low-echogenicity lesions, such as cysts or tumors, by increasing the compared to fundamental imaging. Tissue harmonic imaging (THI), a specific implementation of harmonic imaging, further refines image quality by bandpass filtering to suppress the fundamental frequency echoes while emphasizing the second harmonic. This filtering minimizes artifacts like side lobes, reverberation, and grating lobes that originate near the transducer, allowing clearer visualization of deeper, low-echogenicity tissues. THI improves axial and lateral resolution due to the narrower bandwidth of harmonic signals and has become a standard mode in abdominal and cardiac ultrasound, with reported reductions in noise in clinical settings. The one-way propagation effect—where harmonics form progressively during travel—also contributes to sharper images with less distortion from body wall interfaces. Gain and time-gain compensation (TGC) are fundamental post-processing adjustments that standardize echogenicity across the image depth. Overall amplifies the entire returning signal to brighten the , while TGC applies depth-specific to counteract from and , ensuring uniform brightness from superficial to deep structures. Proper TGC settings prevent over- or under-, which could otherwise mask low-echogenicity areas or introduce false echoes; for instance, inadequate deep compensation might render hypoechoic lesions invisible. These controls are operator-dependent but essential for reproducible echogenicity assessment in routine scans. Spatial enhances perceived echogenicity uniformity by acquiring multiple overlapping images from steered beam angles—typically 3 to 11 views—and averaging them into a composite . This reduces and angular-dependent artifacts, resulting in smoother textures and better delineation of tissue interfaces without altering true echogenicity. The technique is particularly beneficial for low-echogenicity soft tissues, where speckle can obscure subtle variations, and clinical evaluations show improved conspicuity in musculoskeletal and vascular . However, it may slightly reduce frame rates and in dynamic studies. For superficial imaging, simple physical enhancers like or standoff physically optimize acoustic and to boost effective echogenicity. A thick layer of or a dedicated standoff pad positions the focal zone away from the , minimizing near-field artifacts and enabling better resolution of low-echogenicity structures within 1-2 cm of the surface, such as small nodules or vessels. These simple, non-invasive aids are widely used in dermatologic and pediatric to improve signal penetration and reduce distortion from irregular skin contours.

Microbubbles

Properties and Mechanism

Microbubbles used as ultrasound contrast agents consist of a gas core encapsulated by a stabilizing shell, with diameters typically ranging from 1 to 10 µm to ensure intravascular and effective circulation. The gas core is often composed of high-molecular-weight perfluorocarbons, such as or perfluoropropane, which exhibit low in and provide prolonged compared to earlier air-filled designs. The shell is commonly made of phospholipids, such as or , or proteins like , forming a thin layer (approximately 3 nm thick) that reduces gas and while promoting strong acoustic interfaces for enhanced echogenicity. Under exposure, microbubbles interact through , where the causes the to expand and contract, generating backscattered echoes that significantly amplify signal . This can be linear at low pressures but transitions to nonlinear behavior at higher amplitudes, producing frequencies (multiples of the driving ) and subharmonics that improve resolution due to their distinct spectral signatures. At sufficient levels, microbubbles may undergo , involving transient collapse or fragmentation, which results in broadband noise and short-lived enhancement bursts, or stable with sustained . These mechanisms leverage the large mismatch between the gas core and surrounding fluid, leading to efficient scattering of waves. The frequency of microbubbles, at which is maximized and backscattering is strongest, typically falls within 1–5 MHz, aligning closely with diagnostic frequencies for optimal performance. This is primarily determined by bubble size and shell properties, with smaller diameters yielding higher frequencies; for instance, a 1.7 µm microbubble resonates around 5 MHz. Microbubbles exhibit circulatory stability with a of approximately 2–5 minutes, enabling multiple passes through the vascular system before dissolution or clearance. The encapsulating shell plays a critical role in this longevity by minimizing gas leakage into the bloodstream and preventing premature coalescence or dissolution, as uncoated gas bubbles dissolve in under a minute. shells, in particular, balance flexibility for oscillation with sufficient rigidity to maintain integrity under physiological conditions. Bubble size influences their acoustic and hemodynamic properties, with smaller microbubbles (around 1–2 µm) capable of traversing capillary beds due to their compliance and lower tendency to obstruct flow, while larger ones (up to 10 µm) provide stronger scattering signals suitable for imaging in larger vessels. Variations in size distribution affect overall echogenicity, as resonant bubbles dominate the backscattered signal.

Therapeutic and Diagnostic Roles

Microbubbles serve as contrast agents that enhance echogenicity in diagnostic by improving visualization of vascular structures and . In liver lesion characterization, (CEUS) with microbubbles enables precise differentiation of benign and malignant focal lesions, such as (HCC), which typically exhibits hyperenhancement in the arterial followed by washout in the venous . This pattern aids in non-invasive , providing a definitive and reducing the need for in approximately 90% of cases with indeterminate lesions on conventional . Similarly, in , microbubbles facilitate myocardial contrast (MCE) for assessing defects, allowing real-time detection of ischemia during by opacifying the left ventricular chamber and highlighting microvascular flow abnormalities. Vascular applications of microbubbles extend to endovascular procedures, where CEUS improves delineation of plaque borders and in arteries, enhancing procedural guidance during interventions like or coronary . For tumor assessment, targeted microbubbles bind to endothelial markers, revealing uptake patterns that correlate with neovascular density and tumor aggressiveness in cancers such as and , providing a non-invasive surrogate for biopsy-based . Therapeutically, microbubbles enable through ultrasound-triggered , known as sonoporation, where acoustic pressure induces transient membrane pores in cells, facilitating payload release from microbubble carriers directly at disease sites like tumors or ischemic tissues. In targeted imaging, ligand-conjugated microbubbles, such as those bearing anti-vascular endothelial growth factor (VEGF) peptides, selectively adhere to angiogenic receptors on tumor , enabling molecular-level visualization of cancer progression and response to anti-angiogenic therapies. Microbubbles have a favorable safety profile, with agents like Optison (approved by the FDA in 1998) and Definity (approved in 2001) demonstrating low incidence of serious adverse events in millions of administrations worldwide. Rare risks include , occurring in approximately 1 in 10,000 cases, primarily linked to excipients like in certain formulations, but overall cardiopulmonary reactions are infrequent with proper monitoring.

References

  1. [1]
    Ultrasound: Basic understanding and learning the language - PMC
    Echogenicity of the tissue refers to the ability to reflect or transmit US waves in the context of surrounding tissues.[7–9] Whenever there is an interface of ...
  2. [2]
    Echogenicity: Definition, Guide, and Best Practices - Sonoscanner
    Echogenicity refers to a tissue's ability to reflect a portion of the ultrasound waves emitted by the transducer. These variations in echogenicity depend on ...
  3. [3]
    Echogenicity - an overview | ScienceDirect Topics
    Echogenicity is defined as the ability of tissue to return a signal when exposed to an ultrasound beam, which is primarily influenced by the tissue's ...
  4. [4]
    Liver echogenicity: measurement or visual grading? - ScienceDirect
    Liver echogenicity is usually estimated by comparing it to that of the right kidney cortex. Subjective estimation is observer dependent and may be inaccurate.<|control11|><|separator|>
  5. [5]
    History of ultrasound in medicine | Radiology Reference Article
    Feb 17, 2024 · The first written document dealing with the use of waves in spatial orientation dates back to 1794, when an Italian physicist Lazzaro Spallanzani
  6. [6]
    Diagnostic imaging in the 1970s - British Institute of Radiology
    The Danish ultrasound pioneer Hans Holm wrote on abdominal ultrasound in January 1971 (Holm BJR 1971; 44(517): 24-36). There is an interesting illustration ...
  7. [7]
    The echographic characteristics of fatty tissues and tumors - PubMed
    Oct 15, 1978 · The echogenicity of fat has important implications for diagnostic ultrasound: (a) the presence of fat in tissues and masses may be demonstrated by ultrasound ...
  8. [8]
    Ultrasound terminology - Pathology Outlines
    May 26, 2021 · Heterogeneous: nonuniform in echogenicity and is a mixture of hyperechoic and hypoechoic areas; Homogenous: uniform or equally distributed ...<|control11|><|separator|>
  9. [9]
    [PDF] Acoustic Properties of Tissue
    ρ (kg/m3) c (m/s) Z (106 kg/m2/s). Air (25°C). 1.16 344. 0.0004. Water (22°C). 998. 1482. 1.48. Blood. 1060 1584. 1.68. Skeletal muscle 1041 1580.Missing: values | Show results with:values
  10. [10]
    17.7 Ultrasound – College Physics - UCF Pressbooks
    The acoustic impedance can be calculated using Z = ρ v and the values for ρ and v found in Table 5. Solution for (a). (1) Substitute known values from Table 5 ...
  11. [11]
    Ultrasonic Sound - HyperPhysics
    ... bone. 4080. 7.8. Sound reflections will occur at boundaries where the sound ... acoustic impedance of the tissue, with a greater change in impedance at an ...
  12. [12]
    Ultrasound - Medical Imaging Systems - NCBI Bookshelf - NIH
    Acoustic impedance Z, which is measured in g cm−2 s−1, can be computed from the tensile modulus E (elasticity) and the density D of the given medium: Z = ( E ⋅ ...Missing: formula | Show results with:formula
  13. [13]
    [PDF] Clinical Significance of US Artifacts1
    Some artifacts result in image degradation and are generally unwanted, whereas others reveal valuable information about the un- derlying tissue being imaged.
  14. [14]
    [PDF] Using Ultrasonic Reflection Resonance to Probe Stress Wave ...
    The reflection coefficient, R, is determined by the acoustic impedance dis- crepancy of the two layers [1] and given as: R = z2 − z1 z2 + z1. ,. (1) where z1 ...Missing: formula | Show results with:formula
  15. [15]
    Physics of Ultrasound | Radiology Key
    Apr 2, 2017 · Specular reflection occurs when the sound waves encounter large smooth surfaces such as bone, which results in the sound waves being reflected ...
  16. [16]
    Specular Reflection - RCEMLearning
    Specular reflection occurs when the sound pulse encounters a large smooth boundary, such as an organ capsule. Sound is reflected from interfaces where there is ...Missing: echogenicity | Show results with:echogenicity
  17. [17]
    Scattering (ultrasound) | Radiology Reference Article
    Sep 2, 2023 · "Specular reflectors" are tissues with smooth interfaces from which ultrasound waves are reflected in a specular fashion such as vessel wall, ...
  18. [18]
    Ultrasound Physics and Instrumentation - StatPearls - NCBI Bookshelf
    Mar 27, 2023 · In clinical ultrasound, the media involved are air, water, body fluid, soft tissues, blood, and bone. ... soft tissue, known as acoustic impedance ...
  19. [19]
    [PDF] Frequency and concentration dependence of the ultrasonic ... - HAL
    In medical ultrasound, the backscatter coefficient is used to quantify the scattering properties of biological tissues. It is defined as the differential ...Missing: echogenicity | Show results with:echogenicity<|separator|>
  20. [20]
    Attenuation (ultrasound) | Radiology Reference Article
    Apr 10, 2019 · Given a fixed propagation distance, attenuation affects high frequency ultrasound waves to a greater degree than lower frequency waves. This ...
  21. [21]
    Frequency, Penetration and Attenuation - RCEMLearning
    Absorption and scattering are both highly frequency dependent. High frequency sound produces better image resolution, but is attenuated by a smaller depth ...
  22. [22]
    Collagen fiber morphology determines echogenicity of myocardial scar
    We found that myocardial scar tissue appeared either hyperechoic or normoechoic depending on collagen fiber morphology.
  23. [23]
    Liver fat imaging—a clinical overview of ultrasound, CT, and MR ...
    Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate ...<|control11|><|separator|>
  24. [24]
    Basics of Ultrasound: Pitfalls and Limitations - NYSORA
    Conversely, interfaces between soft tissue and bone or the lung generate very strong echoes due to a large acoustic impedance gradient [7]. When an incident ...Basics Of Ultrasound... · 3. Ultrasound Wavelength And... · 4. Ultrasound-Tissue...
  25. [25]
    Effect of chromatin structure on quantitative ultrasound parameters
    Mar 21, 2017 · ... organelles such as mitochondria may be significant scatterers of ultrasound besides chromatin. ... nucleus are prominent ultrasound scatterers ...
  26. [26]
    Standardized Ultrasound Report for Thyroid Nodules
    Feb 23, 2013 · Echogenicity is another important feature to be analyzed in thyroid nodules. The normal thyroid tissue is homogeneously hyperechoic and brighter ...
  27. [27]
    Pediatric Series: Kidney Echogenicity in Children: Clinical ...
    Jul 19, 2019 · Normal medullary pyramids should always be hypoechoic in comparison to the cortex, regardless of how bright the cortex appears in imaging. Next, ...
  28. [28]
    Ovarian Cyst - StatPearls - NCBI Bookshelf
    Ultrasound findings consistent with benign cysts in any age group are thin, smooth walls, an absence of septations, solid components, and internal flow on color ...Ovarian Cyst · Pathophysiology · Evaluation
  29. [29]
    Sonographic Finding of Medial Ankle Subcutaneous Edema and Its ...
    SubQ edema was considered positive when the subQ fat appeared thickened, echogenic, and demonstrated linear to curvilinear hypoechoic to anechoic areas ...<|separator|>
  30. [30]
    Ultrasonographic evaluation of patients with abnormal liver function ...
    On US, the hepatic parenchyma demonstrates increased echogenicity with mild coarsening, often resulting in increased sound beam attenuation and poor penetration ...
  31. [31]
    Typical imaging finding of hepatic infections: a pictorial essay - PMC
    Jul 26, 2020 · On US, the fibrosis bands are defined as a hyperechoic mantle encompassing the anechoic portal vein called the “bull's eye” sign (Fig. 17) [11].
  32. [32]
    Sonographic features of invasive ductal breast carcinomas ...
    Boundary: An echogenic halo boundary zone is a prominent feature to suggest malignancy in a breast mass and was seen in 67 (65%) masses in our study. Thirty six ...
  33. [33]
    Echogenicity of Fibroadenoma and Carcinoma of the Breast ...
    The purpose of this study was to evaluate the role of ultrasonography in differentiation between the echogenic characteristics of carcinoma and those of ...
  34. [34]
    Value of Periappendiceal Fat Sign on Ultrasound in Acute Appendicitis
    Jul 11, 2021 · Increased periappendiceal fat echogenicity is an important ancillary sign of acute appendicitis that helps support its sonographic diagnosis.
  35. [35]
    Increased liver echogenicity at ultrasound examination reflects ...
    Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate ...
  36. [36]
    Benign and malignant characteristics of breast lesions at ultrasound
    Jun 7, 2025 · Benign and malignant characteristics of breast lesions at ultrasound allow the classification as either malignant, intermediate or benign.
  37. [37]
    Heterogeneous echogenicity of the underlying thyroid parenchyma
    Nov 16, 2013 · Heterogeneous echogenicity of the thyroid gland significantly lowers the specificity, PPV, and accuracy of US in the differentiation of thyroid nodules.
  38. [38]
    Acoustic enhancement | Radiology Reference Article
    Jan 13, 2025 · The presence of acoustic enhancement aids in the identification of cystic masses but some solid masses, especially lymphoma, may also show ...
  39. [39]
    Acoustic shadowing | Radiology Reference Article - Radiopaedia.org
    Aug 11, 2025 · Acoustic shadowing (sometimes referred to as posterior acoustic shadowing) is a form of ultrasound artifact. It is characterized by the apparent lack of signal ...Question 2441 · Question 2835 · Question 2402
  40. [40]
    Ultrasound and Doppler US in Evaluation of Superficial Soft-tissue ...
    Feb 27, 2014 · On US, they appear as soft, fluctuating hypoechoic masses. They are encapsulated and often contain cystic component. Nerve sheath tumors. Benign ...
  41. [41]
    Fatty liver deposition and sparing: a pictorial review
    Jun 28, 2011 · On ultrasound, fatty liver is hyperechoic compared with renal cortex and spleen, whereas fatty sparing is isoechoic or hypoechoic.
  42. [42]
    ACR Thyroid Imaging Reporting and Data System (ACR TI-RADS)
    Oct 28, 2025 · The projected risk of malignancy in the original 2017 paper 1 was based on partial analysis of 3433 nodules with cytological results. Partial ...Radiographic features · Risk of malignancy · Developments leading to ACR...
  43. [43]
  44. [44]
    Sonography Vascular and Lymphatic Assessment, Protocols ... - NCBI
    Jan 16, 2023 · Increasing gain on the ultrasound machine makes structures appear more echogenic on grayscale imaging. A high gain may cause a 'blooming ...
  45. [45]
    Tissue harmonic imaging - PMC - PubMed Central - NIH
    An ultrasound beam insonates body tissues and generates such harmonic waves from nonlinear distortion during the transmit phase of the pulse‐echo cycle.
  46. [46]
    A Primer on the Physical Principles of Tissue Harmonic Imaging
    Harmonic frequencies are integer multiples of the fundamental frequency. The majority of current clinical US systems use second harmonic echoes for THI image ...
  47. [47]
    Ultrasound principles and instrumentation - PMC - NIH
    Mar 11, 2024 · Gain/time gain compensation (TGC). The returning echoes are attenuated by absorption, refraction and scattering. It is also known that the ...
  48. [48]
    Ultrasound Image Optimization (“Knobology”): B-Mode - PMC
    Aug 31, 2020 · Use time gain control (TGC)/depth gain control (DGC) if necessary for compensation of strongly enhanced or diminished tissue attenuation.
  49. [49]
    Elevational spatial compounding for enhancing image quality in ...
    Mar 1, 2016 · Elevational spatial compounding can produce substantial noise and speckle suppression as well as visual enhancement of tissue structures even for small ...
  50. [50]
    Utility of a gel stand-off pad in the detection of Doppler signal on ...
    Mar 29, 2019 · The use of a gel stand-off pad allows the detection of otherwise-missed peri- or intra-lesional flow signals on Doppler imaging.
  51. [51]
    A bump: what to do next? Ultrasound imaging of superficial soft ...
    The US findings that might suggest benignity of a soft tissue mass that has a small size, superficial location, homogeneous echo pattern, or hypovascularity.
  52. [52]
  53. [53]
    Microbubble Compositions, Properties and Biomedical Applications
    Microbubbles make excellent contrast agents for ultrasound imaging. The strong echogenicity of microbubbles is a manifestation of their compressibility.
  54. [54]
    “Compression-only” behavior: A second-order nonlinear response of ...
    Apr 8, 2011 · The microbubbles are resonant scatterers at medical ultrasound frequencies of 1–5 MHz. ... The resonance frequency is observed to shift to ...
  55. [55]
    High-Frequency Dynamics of Ultrasound Contrast Agents - PMC - NIH
    Microbubbles with an initial diameter of 1.7 μm are predicted to have a linear resonance frequency of approximately 5 MHz based on equation A.8 in [19]. Theory ...
  56. [56]
    Contrast-Enhanced Ultrasound of Focal Liver Lesions | AJR
    The injection of microbubble ultrasound contrast agents improves the characterization of focal liver lesions that are indeterminate on conventional ultrasound.
  57. [57]
    High correlation between microbubble contrast-enhanced ...
    The goal of this study was to compare the efficacy of microbubble contrast ultrasound in characterizing hepatocellular carcinoma in patients with chronic liver ...
  58. [58]
    Contrast-enhanced ultrasound for characterisation of hepatic lesions ...
    The purpose of this prospective study was to elucidate the efficacy of using contrast-enhanced ultrasound to characterise focal hepatic lesions appearing ...
  59. [59]
    Contrast Echocardiography for Assessing Myocardial Perfusion
    Oct 3, 2023 · MCE was originally conceived as a technique for detecting resting perfusion abnormalities related to ischemia at rest or during stress from coronary artery ...
  60. [60]
    Ultrafast Myocardial Contrast Echocardiography for the Assessment ...
    Oct 2, 2024 · Clinical myocardial contrast echocardiography (MCE) utilizes commercial microbubbles for myocardial perfusion assessment for the detection ...
  61. [61]
    General principles and overview of vascular contrast-enhanced ...
    In terms of plaque delineation, the use of microbubbles improves delineation of the endovascular border, including the ability to distinguish among plaque, ...Ceus Artifacts · Carotid Artery · Peripheral Arteries
  62. [62]
    Microbubble Contrast Agent Use During Invasive Coronary ... - JSCAI
    Jul 31, 2025 · Ultrasound microbubble contrast can be used effectively during invasive coronary Doppler flow measurements to improve the Doppler envelope ...
  63. [63]
    Targeted Contrast-Enhanced Ultrasound Imaging of Tumor ... - NIH
    The purpose of this study was to develop and test a new class of targeting ligands for targeted contrast-enhanced ultrasound imaging of tumor angiogenesis.
  64. [64]
    Imaging Tumor Angiogenesis With Contrast Ultrasound and ...
    Contrast-enhanced ultrasound (CEU) with targeted microbubble contrast agents has recently been used to noninvasively assess expression of endothelial cell ...
  65. [65]
    Ultrasound and Microbubble Guided Drug Delivery - PubMed Central
    Ultrasound mediated drug delivery using microbubbles is a safe and noninvasive approach for spatially localized drug administration.
  66. [66]
    Mechanisms of microbubble-facilitated sonoporation for drug ... - NIH
    Ultrasound excitation of microbubbles has been exploited to increase vascular and cell membrane permeability and facilitate the passage of therapeutic agents ...
  67. [67]
    Targeted Microbubbles for Imaging Tumor Angiogenesis
    Purpose: To evaluate in vivo whole-body biodistribution of microbubbles (MBs) targeted to tumor angiogenesis–related vascular endothelial growth factor (VEGF) ...
  68. [68]
    US Imaging of Tumor Angiogenesis with Microbubbles Targeted to ...
    Feb 1, 2008 · US imaging with contrast microbubbles targeted to VEGFR2 allows noninvasive visualization of VEGFR2 expression in tumor vessels in mice.
  69. [69]
    [PDF] Definity - accessdata.fda.gov
    DEFINITY is an ultrasound contrast agent indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to.Missing: Optison | Show results with:Optison
  70. [70]
    Overview of the 2008 Food and Drug Administration Advisory ...
    Apr 14, 2009 · On June 24, 2008, the FDA convened a panel of experts to review the preclinical safety evaluation of the contrast agents, potential clinical ...
  71. [71]
    Perflutren lipid microspheres for echocardiogram contrast - NIH
    May 7, 2025 · Anaphylactoid reactions to Definity® are very rare [3] and only one case report of anaphylaxis was clearly attributed to polyethylene glycol ( ...
  72. [72]
    Incidence of Severe Adverse Drug Reactions to Ultrasound ...
    13, 14, 15 In 2021, the Food and Drug Administration (FDA) announced 11 cases of anaphylaxis due to polyethylene glycol (PEG)-containing UEAs in patients with ...